Loading
Latest filing published 22 Jan 2013 for SYNERGY PHARMACEUTICALS, INC..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Robert Merrill Hunter across 3 companies, led by Callisto Pharmaceuticals Inc, Cardiff Oncology, Inc. and Synergy Pharmaceuticals, Inc. In total, 4 filings cover trades dated from 26 March 2012 to 17 January 2013.
Purchases make up the whole of the open-market record (1 purchase, €152k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant.
On 22 January 2013 came the latest disclosure, a share grant in Synergy Pharmaceuticals, Inc. The most recent open-market purchase was published on 16 April 2012, 5,304 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations